Newbridge Financial Services Group Inc. Takes $193,000 Position in Danaher Co. (NYSE:DHR)

Newbridge Financial Services Group Inc. acquired a new position in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 840 shares of the conglomerate’s stock, valued at approximately $193,000.

A number of other institutional investors have also recently bought and sold shares of DHR. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the fourth quarter valued at about $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher in the fourth quarter worth about $31,000. Teachers Insurance & Annuity Association of America acquired a new stake in shares of Danaher during the third quarter worth about $39,000. Finally, MidAtlantic Capital Management Inc. bought a new position in shares of Danaher during the 3rd quarter valued at about $40,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on DHR shares. Royal Bank of Canada restated an “outperform” rating and set a $277.00 target price (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Citigroup reduced their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. KeyCorp boosted their price target on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Finally, Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Stock Down 1.5 %

Shares of DHR stock opened at $206.92 on Monday. Danaher Co. has a 52-week low of $205.79 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a market cap of $149.45 billion, a price-to-earnings ratio of 39.19, a PEG ratio of 2.68 and a beta of 0.83. The firm’s 50-day moving average is $232.72 and its 200-day moving average is $251.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share. Sell-side analysts predict that Danaher Co. will post 7.67 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. Danaher’s dividend payout ratio is currently 20.45%.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.